0001209191-16-133851.txt : 20160725
0001209191-16-133851.hdr.sgml : 20160725
20160725170844
ACCESSION NUMBER: 0001209191-16-133851
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160725
FILED AS OF DATE: 20160725
DATE AS OF CHANGE: 20160725
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Audentes Therapeutics, Inc.
CENTRAL INDEX KEY: 0001628738
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461606174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 415-638-6556
MAIL ADDRESS:
STREET 1: 101 MONTGOMERY STREET, SUITE 2650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Versant Ventures IV, LLC
CENTRAL INDEX KEY: 0001456589
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37833
FILM NUMBER: 161782622
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-2211
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET
STREET 2: SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-07-25
1
0001628738
Audentes Therapeutics, Inc.
BOLD
0001456589
Versant Ventures IV, LLC
ONE SANSOME STREET, SUITE 3630
SAN FRANCISCO
CA
94104
0
0
1
0
Common Stock
2016-07-25
4
C
0
1081477
A
1081477
I
By Versant Venture Capital IV, L.P.
Common Stock
2016-07-25
4
C
0
480856
A
1562333
I
By Versant Venture Capital IV, L.P.
Common Stock
2016-07-25
4
C
0
198410
A
1760743
I
By Versant Venture Capital IV, L.P.
Common Stock
2016-07-25
4
C
0
6811
A
6811
I
By Versant Side Fund IV, L.P.
Common Stock
2016-07-25
4
C
0
3029
A
9840
I
By Versant Side Fund IV, L.P.
Common Stock
2016-07-25
4
C
0
1249
A
11089
I
By Versant Side Fund IV, L.P.
Common Stock
2016-07-25
4
P
0
34781
15.00
A
1795524
I
By Versant Venture Capital IV, L.P.
Common Stock
2016-07-25
4
P
0
219
15.00
A
11308
I
By Versant Side Fund IV, L.P.
Series A Preferred Stock
2016-07-25
4
C
0
1081477
D
Common Stock
1081477
0
I
By Versant Venture Capital IV, L.P.
Series B Preferred Stock
2016-07-25
4
C
0
480856
D
Common Stock
480856
0
I
By Versant Venture Capital IV, L.P.
Series C Preferred Stock
2016-07-25
4
C
0
198410
D
Common Stock
198410
0
I
By Versant Venture Capital IV, L.P.
Series A Preferred Stock
2016-07-25
4
C
0
6811
D
Common Stock
6811
0
I
By Versant Side Fund IV, L.P.
Series B Preferred Stock
2016-07-25
4
C
0
3029
D
Common Stock
3029
0
I
By Versant Side Fund IV, L.P.
Series C Preferred Stock
2016-07-25
4
C
0
1249
D
Common Stock
1249
0
I
By Versant Side Fund IV, L.P.
Each share of the issuer's Series A Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its firm commitment initial public offering (the "IPO") pursuant to a registration statement on Form S-1 (File No. 333-208842) under the Securities Act of 1933, as amended (the "Registration Statement"), and had no expiration date.
Versant Ventures IV, LLC ("VV IV") is the general partner of Versant Venture Capital IV, L.P. ("VVC IV"), the record holder of the securities, and disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Each of Thomas Woiwode, a member of the issuer's board of directors, Brian Atwood, Bradley Bolzon, Samuel Colella, Ross Jaffe, William Link, Kirk Nielsen, Robin Praeger, Rebecca Robertson and Charles Warden is a managing member of VV IV and may be deemed to share voting and dispositive power over the securities held by VVC IV. Each of such individuals disclaims beneficial ownership over such securities except to the extent of his or her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Each share of the issuer's Series B Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.
Each share of the issuer's Series C Preferred Stock automatically converted into 1 share of the issuer's Common Stock on July 25, 2016 in connection with the closing of the issuer's sale of its Common Stock in its IPO pursuant to the Registration Statement, and had no expiration date.
VV IV is the general partner of Versant Side Fund IV, L.P. ("VSF IV"), the record holder of the securities, and disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
Each of Thomas Woiwode, a member of the issuer's board of directors, Brian Atwood, Bradley Bolzon, Samuel Colella, Ross Jaffe, William Link, Kirk Nielsen, Robin Praeger, Rebecca Robertson and Charles Warden is a managing member of VV IV and may be deemed to share voting and dispositive power over the securities held by VSF IV. Each of such individuals disclaims beneficial ownership over such securities except to the extent of his or her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
/s/ Robin L. Praeger, Managing Director of Versant Ventures IV, LLC, which is the general partner of each of Versant Venture Capital IV, L.P. and Versant Side Fund IV, L.P.
2016-07-25